News Room

On Friday, hundreds of protesters gathered on the Rutgers University campus to oppose the college's rule that students present evidence of having fully vaccinated against COVID-19 prior to attending on-site classes.

The most recent federal guidance on wearing masks offered a glimmer of hope that the pandemic’s end was inching closer, but it has also caused confusion, anger and worry. On May 13, the U.S. Centers for Disease Control and Prevention recommended that fully vaccinated individuals no longer had to wear masks indoors, except in hospitals, on public transit and in other specified places. In that directive, there was incentive for people who hadn’t yet been vaccinated against COVID-19 to go get their shots, but the guidance also left even experts wondering what it meant for individuals and society as a whole.

This week four experts testified at a US Senate committee about the impacts of personal protective equipment (PPE) and drug shortages during COVID-19, the effectiveness of the Strategic National Stockpile (SNS), and what kind of steps leaders must take to be better prepared for the next public health emergency.

Anytime an executive order of any kind is brought to the table, one would think that only good can come from such efforts. However, a review of this magnitude could also potentially uncover the gaps in our nation’s supply chains.

To understand what’s happening in today’s global economy, one UMass economist said it’s helpful to picture it as a grid filled with connected nodes. When one of those nodes — manufacturing, distribution, shipping, you name it — is disrupted, the impact is felt by everyone. These days, those disruptions are occurring across the supply chain, and for many different reasons, causing costs to soar — both for businesses and their customers. It’s a major concern with no simple solution, and some worry that rising prices may derail what is otherwise looking like an economy in recovery.